Evaluation of the efficacy of oral agar gel administration on prevention of non hemolytic jaundice in normal term neonates; a double blind controlled trial

INTERVENTION: Intervention 1: Oral prescription of solution of 500 miligram of oral agar gel in 2.5 mililiter aquapura every 6 hours for 3 days. Intervention 2: Oral prescription of 2.5 mililiter of aquapura every 6 hours for 3 days. Oral prescription of 2.5 mililiter of aquapura every 6 hours for 3 days Oral prescription of solution of 500 miligram of oral agar gel in 2.5 mililiter aquapura every 6 hours for 3 days Placebo Prevention CONDITION: Neonatal jaundice, unspecified Neonatal jaundice. ; Neonatal jaundice, unspecified PRIMARY OUTCOME: Serum bilirubin level. Timepoint: First day of life, third and 5th days of life after intervention. Method of measurement: JM103‐ skin jaundicometer. INCLUSION CRITERIA: INCLUSION CRITERIA: healthy, term infant with birth weight more than 2500 grams Exclusion criteria: Infants with infection, ABO or Rh incompatibility, G6PD deficiency and signs of lethargy or poor feeding